Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy
复制标题
冯·维勒布兰德因子/ADAMTS13 失衡对 COVID-19 凝血病的影响
DOI:
10.1152/ajpheart.00204.2021
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
Zhang, X. Frank
中科院分区:
文献类型:
--
作者:
Seth, Ryan;McKinnon, Thomas A.;Zhang, X. Frank
The 2019 coronavirus disease (COVID-19) is the disease caused by SARS-CoV-2 infection. Although this infection has been shown to affect the respiratory system, a high incidence of thrombotic events has been observed in severe cases of COVID-19 and in a significant portion of COVID-19 nonsurvivors. Although prior literature has reported on both the coagulopathy and hypercoagulability of COVID-19, the specifics of coagulation have not been fully investigated. Observations of microthrombosis in patients with COVID-19 have brought attention to potential inflammatory endothelial injury. Von Willebrand factor (VWF) and its protease, A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), play an important homeostatic role in responding to endothelial injury. This report provides an overview of the literature investigating the role the VWF/ADAMTS13 axis may have in COVID-19 thrombotic events and suggests potential therapeutic strategies to prevent the progression of coagulopathy in patients with COVID-19.
登录
查看更多内容
影响因子:
41.2
作者:
X. F. Zhang;Xuanhong Cheng
通讯作者:
Xuanhong Cheng
影响因子:
158.5
作者:
Ackermann, Maximilian;Verleden, Stijn E.;Jonigk, Danny
通讯作者:
Jonigk, Danny
影响因子:
4
作者:
Marco A;Marco P
通讯作者:
Marco P
影响因子:
19.7
作者:
Poyiadji N;Cormier P;Patel PY;Hadied MO;Bhargava P;Khanna K;Nadig J;Keimig T;Spizarny D;Reeser N;Klochko C;Peterson EL;Song T
通讯作者:
Song T
影响因子:
2.1
作者:
Shipley T
通讯作者:
Shipley T